Oric Pharmaceuticals ORIC
NASDAQ ORIC
$12.20 -0.32 (-2.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oric Pharmaceuticals (ORIC) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Oric Pharmaceuticals (ORIC) posted Return on Capital Employed [ROCE] of -39.04% for Q2 2026, up 15.03 percentage points from -54.07% a year earlier but down 2.03 percentage points from the prior quarter.

Analysis

Oric Pharmaceuticals (ORIC) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Oric Pharmaceuticals' Return on Capital Employed [ROCE] came in at -44.54%, up 15.45 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -4.98 percentage points (FY2020 to FY2025).
  • In prior years, Oric Pharmaceuticals' Return on Capital Employed [ROCE] was -59.98% in FY2024 (-11.64 pp), -48.35% in FY2023 (-12.71 pp), -35.63% in FY2022 (-7.83 pp) and -27.80% in FY2021 (+11.75 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -60.87% in Q1 2025 to a high of -27.08% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last four quarters, with an average year-over-year change of +1.38 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2026, with a gain of 23.86 percentage points; the weakest was Q1 2025, with a drop of 21.00 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -37.01% (Q1 2026), -35.78% (Q4 2025) and -40.13% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Oric Pharmaceuticals 1.30 Bn 1.30 Bn - -39.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -39.04%
Mar 31, 2026 -37.01%
Dec 31, 2025 -35.78%
Sep 30, 2025 -40.13%
Jun 30, 2025 -54.07%
Mar 31, 2025 -60.87%
Dec 31, 2024 -54.28%
Sep 30, 2024 -45.80%
Jun 30, 2024 -39.06%
Mar 31, 2024 -39.87%
Dec 31, 2023 -45.64%
Sep 30, 2023 -38.42%
Jun 30, 2023 -40.25%
Mar 31, 2023 -42.42%
Dec 31, 2022 -40.39%
Sep 30, 2022 -39.25%
Jun 30, 2022 -33.43%
Mar 31, 2022 -31.11%
Dec 31, 2021 -27.08%
Sep 30, 2021 -30.20%
API Access

Oric Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ORIC&period=max&api_key=YOUR_API_KEY